Carelon Research's Mark Cziraky on why the industry's need for deeper, linked data is driving a shift toward trusted research environments.
Mark Cziraky
Advertisement
Mark Cziraky is president of Carelon Research.
Articles by Mark Cziraky
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Adds Nine Drugmakers to Most-Favored-Nation Program: Report
2
Eli Lilly to Acquire Merida Biosciences for $2.8 Billion
3
The Future Relationship Between AI and Field Reps
4
BioNTech Terminates Phase II Clinical Trial for Cevumeran
5